Browse Articles
Discover research articles across all indexed journals
Association between breast cancer risk factors and blood microbiome in patients with breast cancer
Abstract This study investigated the relationship between risk factors for breast cancer (BC) and the microbiome by comparing the microbiomes of BC patients with fatty liver disease to those with a normal liver. Bacterial extracellular vesicles were collected from each blood sample, and next-generation sequencing was performed. The analysis identified specific microbiome profiles shared among groups with hyperglycaemia, hyperlipidaemia, and high body mass index (BMI), which were then compared with functional biomarkers. In particular, the genus Faecalibacterium was a specific bacterium found in the groups with high concentrations of low-density lipoprotein cholesterol, high BMI, and fatty liver disease. Therefore, when the prognosis of patients with BC was analysed based on Faecalibacterium presence, it was confirmed that patients’ prognoses tended to deteriorate. In this study, BC risk factors, such as hyperglycaemia, hyperlipidaemia, fatty liver, and high BMI, were interconnected through the microbiome. This provides insights into how the risk factors for BC are linked and their impact on the microbiome and human health.
In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations
Linear Dichroism Microscopy Resolves Competing Structural Models of a Synthetic Light-Harvesting Complex
Lightweight visual localization algorithm for UAVs
Palladium-Catalyzed Enantioselective Stereodivergent Desymmetrization of Cyclic 1,4-Allyldiboronates
The clinical efficacy and influencing factors of uterine artery embolization in the treatment of different types of uterine adenomyosis
Using visible and NIR hyperspectral imaging and machine learning for nondestructive detection of nutrient contents in sorghum
How chronic stress warps decision-making
Bidirectional cohort study protocol to construct and validate a prediction model for perioperative pulmonary complications in elderly hip fracture patients
Enabling Selective Mechanochemical Scission of Network Crosslinks by Exchanging Single Carbon Atoms for Silicon
Towards realistic simulation of disease progression in the visual cortex with CNNs
Daily briefing: Meet the scientists who edit Wikipedia
Electrocatalytic Alkene Hydrogenation/Deuteration
Identifying chickpea (Cicer arietinum L.) genotypes rich in ascorbic acid as a source of drought tolerance
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer
Author Correction: Estimating global geographical distribution and ecological niche dynamics of Ammannia coccinea under climate change based on Biomod2
High-Energy, High-Power Sodium-Ion Batteries from a Layered Organic Cathode
Assessment of hydrological loading displacement from GNSS and GRACE data using deep learning algorithms
Ion Irradiation-Induced Coordinatively Unsaturated Zn Sites for Enhanced CO Hydrogenation
Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain
Synaptic vesicle glycoprotein 2A (SV2A) is a presynaptic protein targeted by the antiseizure drug levetiracetam. One or more of the three SV2 genes is expressed in all neurons and is essential to normal neurotransmission. Loss of SV2A results in a seizure phenotype in mice and mutations in humans are also linked to congenital seizures. How SV2A action impacts the epileptic phenotype remains unclear, especially among the diverse neuronal populations that regulate network excitability. This study explored how brain structure and function are affected by SV2A conditional knock-out (SV2A-cKO) in specific neural cell subtypes. We show that SV2A-cKO in all neurons of the postnatal brain triggers lethal seizures, suggesting that the seizures observed in earlier knock-out models were not due to aberrant brain development. Similar lethal seizures are detected in mice in which the loss of SV2A is limited to GABAergic neurons, whereas loss in excitatory neurons produces no noticeable phenotype. No apparent gender difference was ever observed. Further investigation revealed that SV2A-cKO in different GABAergic interneuron populations induces seizure, with variable timescales and severity. Most notably SV2A-cKO in parvalbumin interneurons (PV+) leads to lethal seizures in young animals, while SV2A-cKO in somatostatin (SST) inhibitory neurons results in seizures that were scarcely observed only in adult mice. These results support the crucial role SV2A plays in PV and SST interneurons and suggest that the action of levetiracetam may be due largely to effects on a subset of GABAergic interneurons.